146 related articles for article (PubMed ID: 31595984)
1. HSP90 regulates osteosarcoma cell apoptosis by targeting the p53/TCF-1-mediated transcriptional network.
Yang J; Li YH; He MT; Qiao JF; Sang Y; Cheang LH; Gomes FC; Hu Y; Li ZY; Liu N; Zhang HT; Zha ZG
J Cell Physiol; 2020 Apr; 235(4):3894-3904. PubMed ID: 31595984
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
[TBL] [Abstract][Full Text] [Related]
3. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
4. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
5. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
Staal FJ; Burgering BM; van de Wetering M; Clevers HC
Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
[TBL] [Abstract][Full Text] [Related]
6. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
[TBL] [Abstract][Full Text] [Related]
7. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
8. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells.
Tang X; Zheng D; Hu P; Zeng Z; Li M; Tucker L; Monahan R; Resnick MB; Liu M; Ramratnam B
Nucleic Acids Res; 2014 Mar; 42(5):2988-98. PubMed ID: 24335145
[TBL] [Abstract][Full Text] [Related]
11. p53 and microRNA-34 are suppressors of canonical Wnt signaling.
Kim NH; Kim HS; Kim NG; Lee I; Choi HS; Li XY; Kang SE; Cha SY; Ryu JK; Na JM; Park C; Kim K; Lee S; Gumbiner BM; Yook JI; Weiss SJ
Sci Signal; 2011 Nov; 4(197):ra71. PubMed ID: 22045851
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
13. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid promotes cell cycle arrest and decreases proliferation through WNT/β-catenin modulation in colorectal cancer cells exposed to γ-radiation.
Murad LB; da Silva Nogueira P; de Araújo WM; Sousa-Squiavinato ACM; Rocha MR; de Souza WF; de-Freitas-Junior J; Barcellos-de-Souza P; Bastos LG; Morgado-Díaz JA
Biofactors; 2019 Jan; 45(1):24-34. PubMed ID: 30521071
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
17. Engrailed-1 negatively regulates beta-catenin transcriptional activity by destabilizing beta-catenin via a glycogen synthase kinase-3beta-independent pathway.
Bachar-Dahan L; Goltzmann J; Yaniv A; Gazit A
Mol Biol Cell; 2006 Jun; 17(6):2572-80. PubMed ID: 16571670
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway.
Pon YL; Wong AS
Mol Endocrinol; 2006 Dec; 20(12):3336-50. PubMed ID: 16945989
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]